Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial
DNA methylation, a well-characterized epigenetic modification that is influenced by both environment and genetic variation, has previously been implicated in a number of complex diseases, including cardiovascular disease and stroke. The goal of this study was to evaluate epigenome-wide associations...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2018.00358/full |
id |
doaj-9ccc026da316491ab53cebf6d8f2c65f |
---|---|
record_format |
Article |
spelling |
doaj-9ccc026da316491ab53cebf6d8f2c65f2020-11-24T22:05:36ZengFrontiers Media S.A.Frontiers in Genetics1664-80212018-09-01910.3389/fgene.2018.00358382319Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical TrialNicole M. Davis Armstrong0Wei-Min Chen1Wei-Min Chen2Michael S. Brewer3Stephen R. Williams4Michèle M. Sale5Michèle M. Sale6Bradford B. Worrall7Bradford B. Worrall8Keith L. Keene9Keith L. Keene10Department of Biology, East Carolina University, Greenville, NC, United StatesCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, United StatesDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, United StatesDepartment of Biology, East Carolina University, Greenville, NC, United StatesDepartment of Neurology, University of Virginia, Charlottesville, VA, United StatesCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, United StatesDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, United StatesDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, United StatesDepartment of Neurology, University of Virginia, Charlottesville, VA, United StatesDepartment of Biology, East Carolina University, Greenville, NC, United StatesCenter for Health Disparities, East Carolina University, Greenville, NC, United StatesDNA methylation, a well-characterized epigenetic modification that is influenced by both environment and genetic variation, has previously been implicated in a number of complex diseases, including cardiovascular disease and stroke. The goal of this study was to evaluate epigenome-wide associations with recurrent stroke and the folate one-carbon metabolism-related trait, plasma homocysteine (hcy). Differential methylation analyses were performed on 473,864 autosomal CpG loci, using Illumina HumanMethylation 450K array data in 180 ischemic stroke cases from the Vitamin Intervention for Stroke Prevention (VISP) clinical trial. Linear regression was used to assess associations between number of strokes prior to VISP enrollment and measures of hcy with degree of methylation (β-values), while logistic regression was used to evaluate recurrent stroke status and incident recurrent stroke associations. All regression analyses were stratified by race. Two differentially methylated CpG sites exceeded epigenome-wide significance (p ≤ 1.055 × 10−7) for prior number of strokes (PNS) in European Americans. The top locus, cg22812874, was located in the ankyrin repeat and SOCS box containing 10 gene (ASB10; p = 3.4 × 10−9; β = −0.0308; 95% CI = −0.040, −0.002). Methylation locus cg00340919, located in an intron of the tetratricopeptide repeat domain 37 gene, was also statistically significant (TTC37; p = 8.74 × 10−8; β = −0.0517; 95% CI = −0.069, −0.034). An additional 138 CpG sites met our threshold for suggestive significance (p ≤ 5 × 10−5). We evaluated DNA methylation associated with recurrent stroke and hcy phenotypes across the epigenome. Hypermethylation at two CpG sites located in ASB10 and TTC37 was associated with fewer strokes prior to VISP enrollment. Our findings present a foundation for additional epigenome-wide studies, as well as mechanistic studies into epigenetic marks that influence recurrent stroke risk.https://www.frontiersin.org/article/10.3389/fgene.2018.00358/fullDNA methylationrecurrent strokeVISPassociationfolate one carbon metabolismhomocysteine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicole M. Davis Armstrong Wei-Min Chen Wei-Min Chen Michael S. Brewer Stephen R. Williams Michèle M. Sale Michèle M. Sale Bradford B. Worrall Bradford B. Worrall Keith L. Keene Keith L. Keene |
spellingShingle |
Nicole M. Davis Armstrong Wei-Min Chen Wei-Min Chen Michael S. Brewer Stephen R. Williams Michèle M. Sale Michèle M. Sale Bradford B. Worrall Bradford B. Worrall Keith L. Keene Keith L. Keene Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial Frontiers in Genetics DNA methylation recurrent stroke VISP association folate one carbon metabolism homocysteine |
author_facet |
Nicole M. Davis Armstrong Wei-Min Chen Wei-Min Chen Michael S. Brewer Stephen R. Williams Michèle M. Sale Michèle M. Sale Bradford B. Worrall Bradford B. Worrall Keith L. Keene Keith L. Keene |
author_sort |
Nicole M. Davis Armstrong |
title |
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial |
title_short |
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial |
title_full |
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial |
title_fullStr |
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial |
title_full_unstemmed |
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial |
title_sort |
epigenome-wide analyses identify two novel associations with recurrent stroke in the vitamin intervention for stroke prevention clinical trial |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Genetics |
issn |
1664-8021 |
publishDate |
2018-09-01 |
description |
DNA methylation, a well-characterized epigenetic modification that is influenced by both environment and genetic variation, has previously been implicated in a number of complex diseases, including cardiovascular disease and stroke. The goal of this study was to evaluate epigenome-wide associations with recurrent stroke and the folate one-carbon metabolism-related trait, plasma homocysteine (hcy). Differential methylation analyses were performed on 473,864 autosomal CpG loci, using Illumina HumanMethylation 450K array data in 180 ischemic stroke cases from the Vitamin Intervention for Stroke Prevention (VISP) clinical trial. Linear regression was used to assess associations between number of strokes prior to VISP enrollment and measures of hcy with degree of methylation (β-values), while logistic regression was used to evaluate recurrent stroke status and incident recurrent stroke associations. All regression analyses were stratified by race. Two differentially methylated CpG sites exceeded epigenome-wide significance (p ≤ 1.055 × 10−7) for prior number of strokes (PNS) in European Americans. The top locus, cg22812874, was located in the ankyrin repeat and SOCS box containing 10 gene (ASB10; p = 3.4 × 10−9; β = −0.0308; 95% CI = −0.040, −0.002). Methylation locus cg00340919, located in an intron of the tetratricopeptide repeat domain 37 gene, was also statistically significant (TTC37; p = 8.74 × 10−8; β = −0.0517; 95% CI = −0.069, −0.034). An additional 138 CpG sites met our threshold for suggestive significance (p ≤ 5 × 10−5). We evaluated DNA methylation associated with recurrent stroke and hcy phenotypes across the epigenome. Hypermethylation at two CpG sites located in ASB10 and TTC37 was associated with fewer strokes prior to VISP enrollment. Our findings present a foundation for additional epigenome-wide studies, as well as mechanistic studies into epigenetic marks that influence recurrent stroke risk. |
topic |
DNA methylation recurrent stroke VISP association folate one carbon metabolism homocysteine |
url |
https://www.frontiersin.org/article/10.3389/fgene.2018.00358/full |
work_keys_str_mv |
AT nicolemdavisarmstrong epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT weiminchen epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT weiminchen epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT michaelsbrewer epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT stephenrwilliams epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT michelemsale epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT michelemsale epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT bradfordbworrall epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT bradfordbworrall epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT keithlkeene epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial AT keithlkeene epigenomewideanalysesidentifytwonovelassociationswithrecurrentstrokeinthevitamininterventionforstrokepreventionclinicaltrial |
_version_ |
1725825605051613184 |